A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment. Targeting ...
Morning Overview on MSN
Cancer’s most notorious protein MYC quietly repairs the DNA damage chemo inflicts — block that trick and treatment could hit tumor cells far harder
Chemotherapy drugs like doxorubicin and etoposide work by snapping a cancer cell’s DNA in two. The breaks are supposed to be ...
Morning Overview on MSN
Cancer’s most notorious protein MYC also quietly repairs tumor DNA damage — blocking the trick could make chemotherapy far deadlier to cells it targets
For decades, oncologists have watched a frustrating pattern repeat itself. Tumors fueled by the MYC protein, one of the most ...
A technique that transforms immune cells into cancer-seeking bloodhounds may overcome a roadblock that has hampered immunotherapy for solid tumors, according to a new study by Stanford Medicine ...
Researchers found a new way to kill harmful “zombie” cells that linger after chemotherapy and help cancers become more ...
A newly identified weakness in “zombie” cells may open the door to more precise cancer treatments by turning their own survival strategy against them.
Cancer cells travel through the blood like restless seeds, searching for places to take root. Yet one organ they almost never ...
Circulating tumor cells were first described in 1869 by Thomas Ashworth, an Australian pathologist who observed them in a peripheral blood sample taken from a patient with metastatic cancer. 1 They ...
Researchers discovered an antioxidant, glutathione, that cancer cells appear to be "addicted to" as fuel, opening new pathways for investigation and a potential drug that can restrict the way tumors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results